Ovature trial cut short
15 April, 2009 by Kate McDonaldNovogen’s Marshall Edwards subsidiary to wind up ovarian cancer trial early
Insulin independence for LCT
07 April, 2009 by Kate McDonaldLCT reports patient in early trial off insulin after several porcine islet implants
Plant source for HIV microbicide
02 April, 2009 by Kate McDonaldTransgenic plants can produce large quantities of HIV inhibitor griffithsin
Distinguishing features between moles and melanoma
02 April, 2009 by Kate McDonaldUS researchers develop molecular diagnostic for mole and melanoma pathology
Australia targets the pancreas
26 March, 2009 by Kate McDonaldPancreatic cancer our target in international cancer genome consortium
Long-term diabetes reversal with genetic switch
18 March, 2009 by Kate McDonaldTranscription factor nudges hepatic stem cells into insulin-producing cells in mice
Collective action against HIV
16 March, 2009 by Kate McDonaldNeutralising antibodies against HIV isolated from memory B cells
No synaptic loss for Prana
11 March, 2009 by Kate McDonaldPrana claims compound prevents loss of synapses in Alzheimer’s
Old mum good, old dad bad
10 March, 2009 by Kate McDonaldUQ research finds association between paternal age and inferior cognitive performance
Chloroquine inhibits Hendra virus: study
09 March, 2009 by Kate McDonaldCommon malaria drug chloroquine an effective inhibitor of Hendra and Nipah viruses
Chicken factor for Genavia
09 March, 2009 by Kate McDonaldNZ biotech buys chicken egg technology for Factor VIII
Yeast model for Parkinson’s
27 February, 2009 by Kate McDonaldComplex links between alpha-syn, PARK9 and manganese shown in yeast model
Diagnosing cancers of unknown primaries
27 February, 2009 by Kate McDonaldCircadian, Healthscope and Peter Mac collaborate on new diagnostic
Provisional patent for weight loss compound
27 February, 2009 by Kate McDonaldHealthLinx and Dairy Australia find dairy-derived protein with adipogenic activity
Lorne 2009 profile: Nick Hayward
18 February, 2009 by Graeme O'NeillInherited mutations are only thought to account for one per cent of melanoma cases in Australia, so what about the other 99 per cent?
